Patients Must Be Warned of Breast Implant Risks, F.D.A. Says

The New York Times, October 27, 2021: The FDA has placed black box warnings on breast implant packaging and told manufacturers to sell the implants only to health providers who review the potential risks with patients before surgery, and tell them the risks are even higher for breast cancer patients. The National Center for Health Research asks who will enforce that?

Read More »

New study backs breast implant illness claims by patients

International Consortium of Investigative Journalists, July 2, 2020. A study in a leading plastic surgery journal offers more evidence to support the existence of breast implant illness, a malady reported by thousands of women but dismissed as scientifically unproven by many plastic surgeons and some health authorities.

Read More »